700133Low Energy Cold Plasma Ionisation Air Cleansing Project (LECPI)ClosedGRD Proof of MarketInnovate UKOSIL proposes to introduce LECPI technology to change the chemistry of air in enclosed environments to remove bacteria and other contaminants at source. This is to be achieved by introducing purpose designed units. LECPI enhances air quality by activating oxygen to use its natural qualities to remove bacteria and pollutants. The purpose of a comprehensive marketing report is to verify target markets and analyse their characteristics, volumes and suitability for LECPI technology. Benefits of LECPI in removing bacteria is suited to healthcare and hygiene controlled environments. OSIL has identified this key future market as an opportunity for domestic and export penetration. LECPI produces streams of purifying oxygen ions. These are a harmless natural cleansing agent proven to kill bacteria and remove pollutants. This is achieved by generating low-speed electrons and allowing them to activate oxygen within their environment. This method prevents formation of dangerous ozone and other harmful compounds as produced by other plasma systems. This allows a greater formation of negatively charged oxygen ions to create oxidation reactions. This breaks down odorous chemical components and bacteria cell walls. Negative charge causes oxygen ions to cluster and hydrolyse cell walls allowing particles to become electro-statically charged and become too dense to remain in free circulation. Current uses of plasma ionisation require multiple operational processes to function safely. LECPI has the ability to cleanse the air in a single controlled process. Traditional plasma ionisation technology produces harmful ozone and positively charged ions. The proposal sets out to solve and remove ozone hazards. The project objectives are to research and produce a full marketing and strategic report on hospitals and healthcare institutions and the route to introduction of LECPI technology. There is a lead to other industrial uses if the premium hospital markets could be activated.